Leukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidAntineoplastic Combined Chemotherapy ProtocolsLeukemiaAntineoplastic AgentsLeukemia, Myeloid, AcuteGene Expression Regulation, LeukemicVidarabineLeukemia, B-CellApoptosisTumor Cells, CulturedChemotherapy, AdjuvantTreatment OutcomeB-LymphocytesZAP-70 Protein-Tyrosine KinaseChlorambucilCyclophosphamideDrug Resistance, NeoplasmPrecursor Cell Lymphoblastic Leukemia-LymphomaDoxorubicinAntibodies, MonoclonalLeukemia, ExperimentalCladribineLeukemia, Hairy CellDisease-Free SurvivalCombined Modality TherapyEtoposideAntibodies, Monoclonal, Murine-DerivedAntigens, CD38Myeloid Cell Leukemia Sequence 1 ProteinPrognosisCell Line, TumorProto-Oncogene Proteins c-bcl-2Survival AnalysisCisplatinDrug Administration ScheduleCytarabineLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SurvivalLeukemic InfiltrationSurvival RateAntigens, CD5VincristineHL-60 CellsReceptors, Antigen, B-CellFlow CytometrySalvage TherapyDose-Response Relationship, DrugNeoplasm StagingAntigens, CD20MethotrexateNeoplasm ProteinsLymphoma, Non-HodgkinTime FactorsLymphocytesBone MarrowDrug SynergismLeukemia, T-CellRemission InductionLeukemia L1210Lung NeoplasmsLymphomaLeukemia, MyeloidAntigens, CD19Leukemia, Monocytic, AcuteAntibodies, Monoclonal, HumanizedAntimetabolites, AntineoplasticAntigens, CDDNA, NeoplasmCaspasesRecurrenceDeoxycytidineCarboplatinPaclitaxelRNA, NeoplasmIfosfamideProtein Kinase InhibitorsBryostatinsTransplantation, AutologousBleomycinImmunoglobulin Heavy ChainsT-LymphocytesTumor MicroenvironmentBreast NeoplasmsAntineoplastic Agents, AlkylatingLeukemia Virus, MurineDrug Screening Assays, AntitumorSignal TransductionVinblastinePrednisoneDisease ProgressionK562 CellsLeukemia P388Cell LineMitoxantroneAntibiotics, AntineoplasticProto-Oncogene ProteinsClinical Trials as TopicRNA, MessengerFollow-Up Studies